|
$146,271
|
To support a working group of state health policy experts and stakeholders to examine emerging strategies for addressing the high cost of prescription drugs.
|
2016 - 2017
|
LJAF
|
|
$2,021,350
|
To support the launch of the Center for Prescription Drug Price Action.
|
2017 - 2020
|
LJAF
|
|
$3,684,731
|
To provide educational resources for prescription drug and commercial health care prices.
|
2019 - 2022
|
LJAF
|
